Rosetta Stone 2015 Annual Report Download - page 88

Download and view the complete annual report

Please find page 88 of the 2015 Rosetta Stone annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 155

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155

Table of Contents



Stock Options
The following table summarizes the Company's stock option activity from January 1, 2015 to December 31, 2015:













Options Outstanding, January 1, 2015
2,017,642
$ 13.24
7.32
$ 760,925
Options granted
1,203,031
8.92
Options exercised
(25,009)
4.55
Options cancelled
(1,358,499)
13.16
Options Outstanding, December 31, 2015
1,837,165
10.58
7.70
130,262
Vested and expected to vest at December 31, 2015
1,740,152
10.60
7.63
130,262
Exercisable at December 31, 2015
1,033,366
$ 10.77
6.98
$ 130,262
As of December 31, 2015 and 2014, there was approximately $5.2 million and $6.1 million of unrecognized stock-based compensation expense related
to non-vested stock option awards that is expected to be recognized over a weighted average period of 1.84 and 2.38 years, respectively.
Stock options are granted at the discretion of the Board of Directors or the Compensation Committee (or its authorized member(s)) and expire 10 years
from the date of the grant. Options generally vest over a four-year period based upon required service conditions. No options have performance or market
conditions. The Company calculates the pool of additional paid-in capital associated with excess tax benefits using the "simplified method" in accordance
with ASC 718.
The weighted average remaining contractual term and the aggregate intrinsic value for options outstanding at December 31, 2015 was 7.70 years and
$0.1 million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options exercisable at December 31, 2014
was 7.32 years and $0.8 million, respectively. As of December 31, 2015, options that were vested and exercisable totaled 1,033,366 shares of common stock
with a weighted average exercise price per share of $10.77.
The weighted average grant-date fair value per share of stock options granted was $4.77 and $6.73 for the years ended December 31, 2015 and 2014,
respectively.
The aggregate intrinsic value disclosed above represents the total intrinsic value (the difference between the fair market value of the Company's
common stock as of December 31, 2015, and the exercise price, multiplied by the number of in-the-money options) that would have been received by the
option holders had all option holders exercised their options on December 31, 2015. This amount is subject to change based on changes to the fair market
value of the Company's common stock.
F-32